UK markets open in 1 hour 54 minutes
NIKKEI 225
37,685.38 -774.70 (-2.01%) HANG SENG
17,295.93 +94.66 (+0.55%) CRUDE OIL
82.93 +0.12 (+0.14%) GOLD FUTURES
2,327.10 -11.30 (-0.48%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,516.07 -2,269.83 (-4.22%)
Arrowhead Pharmaceuticals, Inc. (ARWR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 23.78 |
| Open | 23.74 |
| Bid | 23.26 x 400 |
| Ask | 23.31 x 400 |
| Day's range | 22.89 - 23.74 |
| 52-week range | 20.67 - 42.48 |
| Volume | |
| Avg. volume | 1,263,835 |
| Market cap | 2.886B |
| Beta (5Y monthly) | 0.72 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Institutional investors may adopt severe steps after Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) latest 6.6% drop adds to a year losses
Key Insights Significantly high institutional ownership implies Arrowhead Pharmaceuticals' stock price is sensitive to...
- GuruFocus.com
Insider Sell: Chief Discovery/Trans Medicine James Hamilton Sells 6,000 Shares of Arrowhead ...
James Hamilton, Chief Discovery and Translational Medicine Officer at Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR), sold 6,000 shares of the company on April 1, 2024, according to a recent SEC filing.
- GuruFocus.com
Arrowhead Pharmaceuticals Inc CFO Kenneth Myszkowski Sells 40,000 Shares
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) CFO Kenneth Myszkowski sold 40,000 shares of the company's stock on March 6, 2024, according to a recent SEC filing.
© 2024 Yahoo. All rights reserved.